The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Share News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 225.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.442%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 225.50
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS: Melrose non-exec buys shares; TBC director sells

Thu, 24th Jun 2021 21:44

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and not separately reported by Alliance News:

----------

Melrose Industries PLC - London-based industrial turnaround specialist - Says Non-Executive Director Victoria Jarman buys 15,000 shares at a price of GBP1.58 each, totalling GBP23,700. The transaction was completed on Thursday. Also, Non-Executive Director Heather Lawrence acquires 25,000 shares at GBP1.57 each, worth GBP39,250, also on Thursday.

----------

TBC Bank Group PLC - Tbilisi, Georgia-based bank - Says Nikoloz Kurdiani, deputy CEO of JSC TBC Bank, sells 2,950 shares at a price of GBP11.16 each. The transaction, worth GBP32,922, was completed on Tuesday and Wednesday.

----------

Manolete Partners PLC - London-based insolvency litigation financing company - Says Chair Designate Howard Leigh purchases 20,000 shares at a price of GBP2.40 each. This transaction, totalling GBP48,000, was completed on Thursday.

----------

MS International PLC - engineering products manufacturer - Says Senior Independent Non-Executive Director Roger Lane-Smith buys 5,000 shares at a price of 202 pence each. This transaction, totalling GBP10,100, was completed on Wednesday. Also, on Thursday, Lane-Smith buys 15,000 shares at 208p, worth GBP31,200. Following these purchases, Lane-Smith holds an interest in 100,000 shares, representing 0.6% stake.

----------

Oakley Capital Investments Ltd - Bermuda-based investment company - Says Alternate Director David Till acquires 130,000 shares in three transactions on Wednesday at an average price of 359.00 pence each. As a result of this transaction, worth GBP466,700, Till is now interested in 838,910 shares, representing 0.5% stake.

----------

PureTech Health PLC - biotechnology company - Says Bharatt Chowrira, director, president & chief of Business & Strategy, buys 20,000 shares at a price of GBP3.46 each. This transaction, worth GBP69,200, was completed on Wednesday.

----------

By Evelina Grecenko; evelinagrecenko@aliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
10 Nov 2021 18:22

TRADING UPDATES: Permanent TSB sells loan portfolio; Dekel output up

TRADING UPDATES: Permanent TSB sells loan portfolio; Dekel output up

Read more
10 Nov 2021 09:15

Puretech Health receives $100m from sale of 55% stake in Karuna Therapeutics

(Sharecast News) - Biotechnology company Puretech Health has received approximately $100.0m in cash from the sale of a portion of the group's shares in its founded entity Karuna Therapeutics.

Read more
9 Nov 2021 19:18

TRADING UPDATES: Sealand's China progress; Altus finds gold

TRADING UPDATES: Sealand's China progress; Altus finds gold

Read more
6 Oct 2021 06:06

IN BRIEF: PureTech Health's Vedanta posts positive VE303 trial results

IN BRIEF: PureTech Health's Vedanta posts positive VE303 trial results

Read more
5 Oct 2021 22:06

TRADING UPDATES: Inland gets Basildon permission; ICG assets grow

TRADING UPDATES: Inland gets Basildon permission; ICG assets grow

Read more
29 Sep 2021 18:23

TRADING UPDATES: Fulham Shore mulls dividend; LoopUp swings to loss

TRADING UPDATES: Fulham Shore mulls dividend; LoopUp swings to loss

Read more
10 Sep 2021 10:27

PureTech's Vor Biopharma granted FDA fast track for blood cancer drug

PureTech's Vor Biopharma granted FDA fast track for blood cancer drug

Read more
10 Sep 2021 07:38

PureTech Health's Vor wins FDA fast-track approval for cancer drug

(Sharecast News) - Clinical stage biotherapeutics firm PureTech Health on Friday said its founded entity, Vor Biopharma, had won US fast track approval for its leukaemia treatment.

Read more
24 Aug 2021 14:34

Tuesday broker round-up

(Sharecast News) - Coats: Jefferies starts at buy with 97.0p target price.

Read more
24 Aug 2021 13:13

PureTech Health hopes cash will carry it to 2025 amid first half loss

PureTech Health hopes cash will carry it to 2025 amid first half loss

Read more
24 Aug 2021 07:42

PureTech in 'strong' position despite swinging to net loss

(Sharecast News) - Biotechnology company PureTech Health swung to a loss in its first half, it said on Tuesday, amid rising costs.

Read more
23 Aug 2021 19:13

IN BRIEF: PureTech Health's LYT-100 performs well in Phase 1

IN BRIEF: PureTech Health's LYT-100 performs well in Phase 1

Read more
17 Aug 2021 16:07

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
17 Aug 2021 15:39

TRADING UPDATES: Chrysalis backs InfoSum; Argo Blockchain goes green

TRADING UPDATES: Chrysalis backs InfoSum; Argo Blockchain goes green

Read more
13 Aug 2021 14:45

EXECUTIVE CHANGES: Insig AI executive chair and Palace Capital CFO out

EXECUTIVE CHANGES: Insig AI executive chair and Palace Capital CFO out

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.